Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soligenix Inc (SNGX)
:SNGX
Holding SNGX?
Track your performance easily
SNGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.83 - $14.91
Previous CloseN/A
Volume55.16K
Average Volume (3M)425.06K
Market Cap
$5.70M
Enterprise Value$1.11M
Total Cash (Recent Filing)$8.77M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Apr 01, 2025EPS Estimate
-0.95Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.80
Shares Outstanding2,509,499
10 Day Avg. Volume1,194,583
30 Day Avg. Volume425,057
Standard Deviation0.30
R-Squared0.09
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)15.64
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.20
Enterprise Value/Revenue3.05
Enterprise Value/Gross Profit11.43
Enterprise Value/Ebitda-0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
Ownership Overview
18.48%
Insiders
0.38% Mutual Funds
1.86% Other Institutional Investors
79.16% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SNGX FAQ
What was Soligenix Inc’s price range in the past 12 months?
Soligenix Inc lowest stock price was $1.83 and its highest was $14.91 in the past 12 months.
What is Soligenix Inc’s market cap?
Soligenix Inc’s market cap is $5.70M.
When is Soligenix Inc’s upcoming earnings report date?
Soligenix Inc’s upcoming earnings report date is Apr 01, 2025 which is in 73 days.
How were Soligenix Inc’s earnings last quarter?
Soligenix Inc released its earnings results on Nov 08, 2024. The company reported -$0.78 earnings per share for the quarter, beating the consensus estimate of -$1.39 by $0.61.
Is Soligenix Inc overvalued?
According to Wall Street analysts Soligenix Inc’s price is currently Overvalued.
Does Soligenix Inc pay dividends?
Soligenix Inc does not currently pay dividends.
What is Soligenix Inc’s EPS estimate?
Soligenix Inc’s EPS estimate is -0.95.
How many shares outstanding does Soligenix Inc have?
Soligenix Inc has 2,509,499 shares outstanding.
What happened to Soligenix Inc’s price movement after its last earnings report?
Soligenix Inc reported an EPS of -$0.78 in its last earnings report, beating expectations of -$1.39. Following the earnings report the stock price went up 0.865%.
Which hedge fund is a major shareholder of Soligenix Inc?
Currently, no hedge funds are holding shares in SNGX
---
Company Description
Soligenix Inc
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
---
Technical Analysis
Aethlon Medical
―
Zomedica Pharmaceuticals
―
Ibio
―
Oragenics
―
Cyclacel Pharmaceuticals
―
Medicinova
―
---